Mankind Pharma gains on the BSE

05 Jun 2025 Evaluate

Mankind Pharma is currently trading at Rs. 2357.25, up by 10.55 points or 0.45% from its previous closing of Rs. 2346.70 on the BSE.

The scrip opened at Rs. 2351.15 and has touched a high and low of Rs. 2375.10 and Rs. 2347.65 respectively. So far 2458 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 3050.00 on 23-Dec-2024 and a 52 week low of Rs. 1910.10 on 05-Aug-2024.

Last one week high and low of the scrip stood at Rs. 2546.00 and Rs. 2335.35 respectively. The current market cap of the company is Rs. 97184.03 crore.

The promoters holding in the company stood at 72.70%, while Institutions and Non-Institutions held 24.37% and 2.93% respectively.

ISS ESG has voluntarily issued an Environmental, Social and Governance (ESG) Corporate Rating Report to Mankind Pharma on June 3, 2025. As per the report, the Company has been assigned an overall ESG score of 38.98 (Rating: C-). The company has not verified any data on which this rating has been issued.

Mankind Pharma is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

Mankind Pharma Share Price

2204.70 -3.65 (-0.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×